Resmed RMD
NYSE RMD
$224.99 -3.51 (-1.54%)
At close: Sep 18, 2026 · 4:00 PM EDT

Resmed (RMD) FCF Margin Growth (1y) (2010 - 2026)

Analysis

Resmed (RMD) FCF Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn 194.00
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn 984.00
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn 641.00
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn 66.00
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn 119.00
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn 1,788.00
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn -395.00
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn -1,013.00
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn -177.00
10 Steris 20.01 Bn 19.54 Bn 684.20 Mn -473.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,013.00
Mar 31, 2026 -683.00
Dec 31, 2025 -59.00
Sep 30, 2025 590.00
Jun 30, 2025 375.00
Mar 31, 2025 1,137.00
Dec 31, 2024 101.00
Sep 30, 2024 188.00
Jun 30, 2024 1,586.00
Mar 31, 2024 910.00
Dec 31, 2023 1,166.00
Sep 30, 2023 2,160.00
Jun 30, 2023 1,253.00
Mar 31, 2023 1,474.00
Dec 31, 2022 -1,138.00
Sep 30, 2022 1,193.00
Jun 30, 2022 -1,711.00
Mar 31, 2022 -1,412.00
Dec 31, 2021 430.00
Sep 30, 2021 -2,764.00